Endoscopy 2014; 46(01): 22-29
DOI: 10.1055/s-0033-1353603
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms

Ken Kamata
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Masayuki Kitano
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Masatoshi Kudo
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Hiroki Sakamoto
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Kumpei Kadosaka
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Takeshi Miyata
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Hajime Imai
1   Department of Gastroenterology and Hepatology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Kiyoshi Maekawa
2   Section of Abdominal Ultrasound, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Takaaki Chikugo
3   Department of Pathology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Masashi Kumano
4   Department of Radiology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Tomoko Hyodo
4   Department of Radiology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Takamichi Murakami
4   Department of Radiology, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Yasutaka Chiba
5   Division of Biostatistics, Clinical Research Center, Kinki University Faculty of Medicine, Osaka-sayama, Japan
,
Yoshifumi Takeyama
6   Department of Surgery, Kinki University Faculty of Medicine, Osaka-sayama, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 26. Dezember 2012

accepted after revision 18. September 2013

Publikationsdatum:
11. November 2013 (online)

Background and study aims: Pancreatic ductal adenocarcinomas (PDAC) sometimes arise in patients with intraductal papillary mucinous neoplasms (IPMNs). This study examined the incidence of PDACs concomitant to or derived from branch duct IPMNs. The usefulness of endoscopic ultrasonography (EUS) relative to other imaging methods for detecting these tumors was also assessed.

Patients and methods: This retrospective study used data from clinical records and imaging studies that were collected prospectively. During 2001 – 2009, 167 consecutive patients with IPMNs underwent EUS, ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI). The 102 patients whose branch duct IPMNs lacked mural nodules/symptoms and thus did not qualify for resection were followed up by semiannual EUS and annual ultrasonography, CT, and MRI. The sensitivity and specificity with which the four modalities detected IPMN-derived and -concomitant PDACs at the first examination and throughout the study period were evaluated. The rate of PDAC development during follow-up was analyzed by the Kaplan–Meier method.

Results: A total of 17 IPMN-derived and 11 IPMN-concomitant PDACs were diagnosed at the first examination. Lesions that did not qualify for resection or chemotherapy were followed up for a median of 42 months. Seven IPMN-concomitant PDACs and no IPMN-derived PDACs were detected during follow-up. The 3- and 5-year rates of IPMN-concomitant PDAC development were 4.0 % and 8.8 %, respectively. At the first examination, EUS was superior to other imaging modalities in terms of IPMN-derived and -concomitant PDAC detection. Throughout the study period, including follow-up, EUS was significantly better at detecting IPMN-concomitant PDACs than the other modalities.

Conclusions: IPMN-concomitant PDACs are quite often found at diagnosis and during follow-up. EUS examination of the whole pancreas plays an important role in the management of IPMNs as it allows the early detection of these small invasive carcinomas.

 
  • References

  • 1 Seki M, Yanagisawa A, Ohta H et al. Surgical treatment of intraductal papillary mucinous tumor (IPMT) of the pancreas: operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT. J Hepatobiliary Pancreat Surg 2003; 10: 147-155
  • 2 Kloppel G, Kosmahl M. Cystic lesions and neoplasm of the pancreas: the features are becoming clearer. Pancreatology 2001; 1: 648-655
  • 3 Baumgaertner I, Corcos O, Couvelard A et al. Prevalence of extrapancreatic cancers in patients with histologically proven intraductal papillary mucinous neoplasms of the pancreas: a case–control study. Am J Gastroenterol 2008; 103: 2878-2882
  • 4 Nagai K, Doi R, Ito T et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009; 16: 353-358
  • 5 Kloppel G, Solcia E, Longnecker DS et al. World Health Organization international histological classification of tumors. Histological typing of tumors of the exocrine pancreas. 2nd. edn. Springer; Berlin: 1996: 1-61
  • 6 Kloppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology 1998; 45: 1981-1985
  • 7 Bournet B, Kirzin S, Carrere N et al. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. J Gastroenterol Hepatol 2009; 24: 1211-1217
  • 8 Tanaka M, Chari S, Adsay V et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasm and mucinous cystic neoplasms of the pancreas . Pancreatology 2006; 6: 17-32
  • 9 Sohn TA, Yeo CJ, Cameron JL et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 2001; 234: 313-321
  • 10 Maire F, Hammel P, Terris B et al. Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002; 51: 717-722
  • 11 Woo SM, Ryu JK, Lee SH et al. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 2008; 36: 50-55
  • 12 Komori T, Ishikawa O, Ohigashi H et al. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation. Jpn J Clin Oncol 2002; 32: 146-151
  • 13 Yamaguchi k, Ohuchida J, Ohtsuka T et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002; 2: 484-490
  • 14 Kamisawa T, Tu Y, Egawa N et al. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005; 11: 5688-5690
  • 15 Uehara H, Nakaizumi A, Ishikawa O et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008; 57: 1561-1565
  • 16 Tada M, Kawabe T, Arizumi M et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 2006; 4: 1265-1270
  • 17 Koito K, Namieno T, Nagakawa T et al. Solitary cystic tumor of the pancreas: EUS-pathologic correlation. Gastrointest Endosc 1997; 45: 268-276
  • 18 Yamaguchi K, Tanaka M. Radiologic imagings of cystic neoplasms of the pancreas. Pancreatology 2001; 1: 633-636
  • 19 Ahmad NA, Kochman ML, Lewis JD et al. Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?. Am J Gastroenterol 2001; 96: 3295-3300
  • 20 Kubo H, Nakamura K, Itaba S et al. Differential diagnosis of cystic tumors of the pancreas by endoscopic ultrasonography. Endoscopy 2009; 41: 684-689
  • 21 Tanaka M, Fernández-del Castillo C, Adsay V et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197
  • 22 Yamaguchi K, Kanemitsu S, Hatori T et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011; 40: 571-580
  • 23 Kobari M, Egawa S, Shibuya K et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999; 134: 1131-1136
  • 24 Matsumoto T, Aramaki M, Yada K et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003; 36: 261-265
  • 25 Sugiyama M, Izumisato Y, Abe N et al. Predictive factors for malignancy in intraductal papillary mucinous tumors of the pancreas. Br J Surg 2003; 90: 1244-1249
  • 26 Salvia R, Femandez-del Castillo C, Bassi C et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239: 678-685
  • 27 Shima Y, Mori M, Takakura N et al. Diagnosis and management of cystic pancreatic tumors with mucin production. Br J Surg 2000; 87: 1041-1047
  • 28 Rodriguez JR, Salvia R, Crippa S et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007; 133: 72-79
  • 29 Salvia R, Crippa S, Falconi M et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?. Gut 2007; 56: 1086-1090
  • 30 Schmidt CM, White PB, Waters JA et al. intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007; 246: 644-654
  • 31 Tanno S, Nakano Y, Nishikawa T et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008; 57: 339-343
  • 32 Chari ST, Yadav D, Smyrk TC et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002; 123: 1500-1507
  • 33 Sohn TA, Yeo CJ, Cameron JL et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004; 239: 788-797
  • 34 D’Angelica M, Brennan MF, Suriawinata AA et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Sur 2004; 239: 400-408